2 results
Approved WMOCompleted
The purpose of this studie is to evaluate the bioequivalence of canagliflozin.
Approved WMOPending
The central hypothesis of this project is that atorvastatin (added on standard antihypertensive treatment ARB) causes a substantial decrease in MSNA in hypertensive patients with CKD.